Magellan Health (MGLN) Tops Q4 EPS Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Jefferies Reiterates Buy on Magellan Health (MGLN) Following 4Q - PT to $77
March 1, 2016 9:35 AM ESTJefferies reiterated a Buy rating on Magellan Health Services (NASDAQ: MGLN), and raised the price target to $77.00 (from $73.00), following the company's 4Q.
Analyst David Styblo commented, "We still believe MGLN is undervalued despite today's surge (+8% vs S&P's -0.3%). The Healthcare and Pharmacy Solution... More



